Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring Metered Dose Inhalation (MDI) Volume and Timing With a Respimetrix Device in Obstructive Lung Disease.

NCT05495256 is registered in ClinicalTrials.gov with Pulmonary Critical Care Associates of Baltimore as lead sponsor.

NCT NCT05495256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05495256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring Metered Dose Inhalation (MDI) Volume and Timing With a Respimetrix Device in Obstructive Lung Disease.
Lead sponsor
Pulmonary Critical Care Associates of Baltimore
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2021
Completion date
March 22, 2022
Enrollment
74 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, copd